Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Evidence Mounts For Calcium CVD Association, But Tailored RCTs Needed

This article was originally published in The Tan Sheet

Executive Summary

A JAMA Internal Medicine study that finds high doses of calcium supplementation are associated with an increased risk of heart disease in men does not bode well for the nutrient’s reputation. Stakeholders agree additional randomized clinical trials are needed to “close the book” on the growing debate, which an industry representative says is no reason to stop taking supplements.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106222

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel